Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
0.280
-0.009 (-3.08%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $17.07 million as of July 22, 2024. Its market cap has decreased by -86.26% in one year.
Market Cap
17.07M
Enterprise Value
-34.18M
1-Year Change
-86.26%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $229.70M to $17.07M, a decrease of -92.57%. That is a compound annual growth rate of -46.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 17.10M | -93.79% |
| Dec 29, 2023 | 275.40M | 175.68% |
| Dec 30, 2022 | 99.90M | 76.19% |
| Dec 31, 2021 | 56.70M | -61.53% |
| Dec 31, 2020 | 147.40M | -35.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synlogic | 18.15M |
| Aeterna Zentaris | 17.91M |
| Biotricity | 17.70M |
| Conduit Pharmaceuticals | 17.58M |
| Aptorum Group | 17.26M |
| VBI Vaccines | 17.06M |
| Kindly MD | 17.05M |
| Sensei Biotherapeutics | 16.78M |